Nature Medicine, Published online: 07 February 2025; doi:10.1038/s41591-025-03510-3
A small but in-depth study of allogeneic CAR T cell therapy in patients with high-risk neuroblastoma shows feasibility and potential efficacy, and mechanistic insights reveal pathways to improved functionality of CAR T cells in solid tumors.
